Sulfiredoxin Promotes Cancer Cell Invasion through Regulation of the miR143-Fascin Axis
- 19 May 2022
- journal article
- research article
- Published by Taylor & Francis Ltd in Molecular and Cellular Biology
- Vol. 42 (5), e0005122
- https://doi.org/10.1128/mcb.00051-22
Abstract
Intracellular antioxidant enzymes are critical for maintenance of redox homeostasis, but whether and how they contribute to the malignancy of cancer cells remains poorly understood. Intracellular antioxidant enzymes are critical for maintenance of redox homeostasis, but whether and how they contribute to the malignancy of cancer cells remains poorly understood. Sulfiredoxin (Srx) is a unique oxidoreductase in that it not only restores peroxidase activity of peroxiredoxins (Prxs) but also functions as a pivotal stimulator of oncogenic signaling. We found that abnormally high level of Srx promotes colorectal cancer (CRC) malignancy by stimulating gelatin degradation, invadopodia formation, and cell invasion. Fascin, an actin-bundling protein, was discovered and validated as one of the critical downstream targets of Srx activation. We demonstrated that depletion of Srx in CRC cells leads to upregulation of miR-143-3p, which mediates degradation of fascin mRNA through binding to conserved sites within the 3 ' untranslated region (UTR). Depletion of fascin in CRC cells recapitulates the effect of Srx loss, and restoration of fascin in Srx-depleted cells by miR-143-3p inhibitor or overexpression rescues defects in cell invasion. Therefore, our data demonstrate that the Srx-miR143-fascin axis plays a key role in promoting the malignancy of human CRC cells. In the future, the Srx-miR143-fascin axis can be used as a functional pathway to evaluate the efficacy of therapeutic drugs or be targeted to develop promising chemotherapeutics for treatment of CRC patients.Keywords
Funding Information
- Kentucky Lung Cancer Research Program (KLCRP2016)
- American Cancer Society (RSG-16-213-01-TBE)
- HHS | NIH | National Cancer Institute (R01CA222596, P30CA177558)
- U.S. Department of Defense (W81XWH-16-1-0203)
This publication has 57 references indexed in Scilit:
- The conformational bases for the two functionalities of 2-cysteine peroxiredoxins as peroxidase and chaperoneJournal of Experimental Botany, 2013
- Sulfiredoxin Redox-Sensitive Interaction with S100A4 and Non-Muscle Myosin IIA Regulates Cancer Cell MotilityBiochemistry, 2012
- The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and functionNature Reviews Molecular Cell Biology, 2011
- Sulfiredoxin–Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signalingProceedings of the National Academy of Sciences of the United States of America, 2011
- miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasivenessOncogene, 2010
- Migrastatin analogues target fascin to block tumour metastasisNature, 2010
- Protein Engineering of the Quaternary Sulfiredoxin·Peroxiredoxin Enzyme·Substrate Complex Reveals the Molecular Basis for Cysteine Sulfinic Acid PhosphorylationOnline Journal of Public Health Informatics, 2009
- Deglutathionylation of 2-Cys Peroxiredoxin Is Specifically Catalyzed by SulfiredoxinOnline Journal of Public Health Informatics, 2009
- Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignanciesProceedings of the National Academy of Sciences of the United States of America, 2008
- Structure of the sulphiredoxin–peroxiredoxin complex reveals an essential repair embraceNature, 2008